
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
Xi Sun, Yue Hu, Jing Wu, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 51
Xi Sun, Yue Hu, Jing Wu, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 51
Showing 1-25 of 51 citing articles:
Splicing factor SF3B4 acts as a switch in cancer cell senescence by regulating p21 mRNA stability
Donghee Kang, Jee Young Sung, Hyun Jung Hwang, et al.
Cancer Letters (2025), pp. 217530-217530
Closed Access | Times Cited: 2
Donghee Kang, Jee Young Sung, Hyun Jung Hwang, et al.
Cancer Letters (2025), pp. 217530-217530
Closed Access | Times Cited: 2
The expression of chromosome 19 miRNA cluster members during insulin sensitivity changes in pregnancy
Fernanda Alvarado, Tianjiao Chu, Patrick M. Catalano, et al.
Placenta (2025) Vol. 161, pp. 23-30
Closed Access | Times Cited: 1
Fernanda Alvarado, Tianjiao Chu, Patrick M. Catalano, et al.
Placenta (2025) Vol. 161, pp. 23-30
Closed Access | Times Cited: 1
SMC1A regulated by KIAA1429 in m6A-independent manner promotes EMT progress in breast cancer
Xu Zhang, Xinyuan Dai, Jiayi Qian, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 27, pp. 133-146
Open Access | Times Cited: 52
Xu Zhang, Xinyuan Dai, Jiayi Qian, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 27, pp. 133-146
Open Access | Times Cited: 52
The RNA-Binding Motif Protein Family in Cancer: Friend or Foe?
Zhigang Li, Qingyu Guo, Jiaxin Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 49
Zhigang Li, Qingyu Guo, Jiaxin Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 49
RNA-binding proteins: Underestimated contributors in tumorigenesis
Yubo Zhao, Cristina Mir, Yoelsis García-Mayea, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 431-444
Closed Access | Times Cited: 34
Yubo Zhao, Cristina Mir, Yoelsis García-Mayea, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 431-444
Closed Access | Times Cited: 34
Identification of candidate genes associated with the pathogenesis of small cell lung cancer via integrated bioinformatics analysis
Yi Liao, Guofang Yin, Xue Wang, et al.
Oncology Letters (2019)
Open Access | Times Cited: 43
Yi Liao, Guofang Yin, Xue Wang, et al.
Oncology Letters (2019)
Open Access | Times Cited: 43
A Proteomic Investigation to Discover Candidate Proteins Involved in Novel Mechanisms of 5-Fluorouracil Resistance in Colorectal Cancer
Mario Ortega Duran, Sadr ul Shaheed, Chris W. Sutton, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 342-342
Open Access | Times Cited: 5
Mario Ortega Duran, Sadr ul Shaheed, Chris W. Sutton, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 342-342
Open Access | Times Cited: 5
LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex‐mediated changes in chromatin structure in lung adenocarcinoma
Panqi Fang, Hao Chen, Zhifei Ma, et al.
Cancer Communications (2021) Vol. 41, Iss. 7, pp. 596-614
Open Access | Times Cited: 28
Panqi Fang, Hao Chen, Zhifei Ma, et al.
Cancer Communications (2021) Vol. 41, Iss. 7, pp. 596-614
Open Access | Times Cited: 28
Targeting the “undruggable”: RNA-binding proteins in the spotlight in cancer therapy
Cristina Mir, Yoelsis García-Mayea, Matilde E. Lleonart
Seminars in Cancer Biology (2022) Vol. 86, pp. 69-83
Closed Access | Times Cited: 19
Cristina Mir, Yoelsis García-Mayea, Matilde E. Lleonart
Seminars in Cancer Biology (2022) Vol. 86, pp. 69-83
Closed Access | Times Cited: 19
Repression of apelin Furin cleavage sites provides antimetastatic strategy in colorectal cancer
Béatrice Demoures, Fabienne Soulet, Jean Descarpentrie, et al.
EMBO Molecular Medicine (2025)
Open Access
Béatrice Demoures, Fabienne Soulet, Jean Descarpentrie, et al.
EMBO Molecular Medicine (2025)
Open Access
RBMS2 Chemosensitizes Breast Cancer Cells to Doxorubicin by Regulating BMF Expression
Feng Xu, Tian Xia, Qitong Xu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 4, pp. 1724-1736
Open Access | Times Cited: 17
Feng Xu, Tian Xia, Qitong Xu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 4, pp. 1724-1736
Open Access | Times Cited: 17
Unlocking the potential of beta sitosterol: Augmenting the suppression of oral cancer cells through extrinsic and intrinsic signalling mechanisms
Selvaraj Jayaraman, Sathan Raj Natarajan, Bhuvaneswari Ponnusamy, et al.
The Saudi Dental Journal (2023) Vol. 35, Iss. 8, pp. 1007-1013
Open Access | Times Cited: 10
Selvaraj Jayaraman, Sathan Raj Natarajan, Bhuvaneswari Ponnusamy, et al.
The Saudi Dental Journal (2023) Vol. 35, Iss. 8, pp. 1007-1013
Open Access | Times Cited: 10
Modulation of Calcium Signaling on Demand to Decipher the Molecular Mechanisms of Primary Aldosteronism
Bakhta Fedlaoui, Teresa Cosentino, Zeina R. Al Sayed, et al.
Hypertension (2025)
Open Access
Bakhta Fedlaoui, Teresa Cosentino, Zeina R. Al Sayed, et al.
Hypertension (2025)
Open Access
MiR-4319 hinders YAP expression to restrain non-small cell lung cancer growth through regulation of LIN28-mediated RFX5 stability
Yi Yang, He Li, Yu Liu, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 115, pp. 108956-108956
Open Access | Times Cited: 29
Yi Yang, He Li, Yu Liu, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 115, pp. 108956-108956
Open Access | Times Cited: 29
Oncogenic action of the exosome cofactor RBM7 by stabilization of CDK1 mRNA in breast cancer
Pei-Wen Xi, Xu Zhang, Lei Zhu, et al.
npj Breast Cancer (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 26
Pei-Wen Xi, Xu Zhang, Lei Zhu, et al.
npj Breast Cancer (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 26
RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities
Shimeng Wang, Hexing Sun, Guan‐Yuan Chen, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 195, pp. 104271-104271
Open Access | Times Cited: 3
Shimeng Wang, Hexing Sun, Guan‐Yuan Chen, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 195, pp. 104271-104271
Open Access | Times Cited: 3
Long non‑coding RNA PCAT6 promotes the development of osteosarcoma by increasing MDM2 expression
Xiliang Guan, Yufen Xu, Ju-fen Zheng
Oncology Reports (2020) Vol. 44, Iss. 6, pp. 2465-2474
Open Access | Times Cited: 23
Xiliang Guan, Yufen Xu, Ju-fen Zheng
Oncology Reports (2020) Vol. 44, Iss. 6, pp. 2465-2474
Open Access | Times Cited: 23
Circ_0000144 acts as a miR-1178-3p decoy to promote cell malignancy and angiogenesis by increasing YWHAH expression in papillary thyroid cancer
Yinli Ma, Dan Yang, Pingan Guo
Journal of Otolaryngology - Head and Neck Surgery (2022) Vol. 51, Iss. 1
Open Access | Times Cited: 13
Yinli Ma, Dan Yang, Pingan Guo
Journal of Otolaryngology - Head and Neck Surgery (2022) Vol. 51, Iss. 1
Open Access | Times Cited: 13
miR-155 Accelerates the Growth of Human Liver Cancer Cells by Activating CDK2 via Targeting H3F3A
Xiaoru Xin, Yanan Lu, Sijie Xie, et al.
Molecular Therapy — Oncolytics (2020) Vol. 17, pp. 471-483
Open Access | Times Cited: 20
Xiaoru Xin, Yanan Lu, Sijie Xie, et al.
Molecular Therapy — Oncolytics (2020) Vol. 17, pp. 471-483
Open Access | Times Cited: 20
RNA binding motif 4 inhibits the replication of ebolavirus by directly targeting 3′-leader region of genomic RNA
Linjin Fan, Yulong Wang, Hongxin Huang, et al.
Emerging Microbes & Infections (2024)
Open Access | Times Cited: 2
Linjin Fan, Yulong Wang, Hongxin Huang, et al.
Emerging Microbes & Infections (2024)
Open Access | Times Cited: 2
LINC01094 promotes gastric cancer through dual targeting of CDKN1A by directly binding RBMS2 and HDAC1
Xinyi Zhou, Cheng Gu, Linmei Xiao, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Xinyi Zhou, Cheng Gu, Linmei Xiao, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Prognostic value and gene regulatory network of CMSS1 in hepatocellular carcinoma
Cheng Chen, Caiming Wang, Wei Liu, et al.
Cancer Biomarkers (2023) Vol. 39, Iss. 4, pp. 361-370
Open Access | Times Cited: 6
Cheng Chen, Caiming Wang, Wei Liu, et al.
Cancer Biomarkers (2023) Vol. 39, Iss. 4, pp. 361-370
Open Access | Times Cited: 6
NFIB promotes the progression of gastric cancer by upregulating circMAP7D1 to stabilize HER2 mRNA
Huimin Yang, Zhengzhen Wu, Xin Liu, et al.
Molecular Medicine Reports (2021) Vol. 23, Iss. 4
Open Access | Times Cited: 14
Huimin Yang, Zhengzhen Wu, Xin Liu, et al.
Molecular Medicine Reports (2021) Vol. 23, Iss. 4
Open Access | Times Cited: 14
LSD1 downregulates p21 expression in vascular smooth muscle cells and promotes neointima formation
Baohui Yuan, He Liu, Xiaohua Pan, et al.
Biochemical Pharmacology (2022) Vol. 198, pp. 114947-114947
Closed Access | Times Cited: 9
Baohui Yuan, He Liu, Xiaohua Pan, et al.
Biochemical Pharmacology (2022) Vol. 198, pp. 114947-114947
Closed Access | Times Cited: 9
Exploring Amodiaquine’s Repurposing Potential in Breast Cancer Treatment—Assessment of In-Vitro Efficacy & Mechanism of Action
Vineela Parvathaneni, Rameswari Chilamakuri, Nishant S. Kulkarni, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11455-11455
Open Access | Times Cited: 8
Vineela Parvathaneni, Rameswari Chilamakuri, Nishant S. Kulkarni, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11455-11455
Open Access | Times Cited: 8